The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …

Although COVID-19 presents primarily as a lower respiratory tract infection transmitted via
air droplets, increasing data suggest multiorgan involvement in patients that are infected …

At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2;
SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around the world, with …

The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown.
We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest …

The severity and outcome of coronavirus disease 2019 (COVID-19) largely depends on a
patient's age. Adults over 65 years of age represent 80% of hospitalizations and have a 23 …

We performed RNA-seq and high-resolution mass spectrometry on 128 blood samples from
COVID-19-positive and COVID-19-negative patients with diverse disease severities and …

Background Haematopoietic stem-cell transplantation (HSCT) recipients are considered at
high risk of poor outcomes after COVID-19 on the basis of their immunosuppressed status …

Susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
and the risk of mortality among people living with human immunodeficiency virus …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

Importance In late December 2019, an outbreak caused by a novel severe acute respiratory
syndrome coronavirus 2 emerged in Wuhan, China. Data on the clinical characteristics and …